Direct Genetics Referral Pathway for High-Grade Serous Ovarian Cancer Patients: The “Opt-Out” Process

Table 2

Opt-out pathway referral outcomes.

Referral outcome (n=168)	N (%)
Opt-out of referral process (cancelled by surgeon)	1 (0.6%)
Opt-in to referral process	167 (99.4%)
Appointments held (n=167 )
Completed or test results pending	133 (79.6 %)
Appointments not held (n=167 )	34 (20.4 %)
Appointment declined by patient	10 (29.4%)
Patient died before appointment date	8 (23.5%)
Patient cancelled appointment	14 (41.2%)
Patient moved out of hospital network	2 (5.9%)

Referral outcomes are based on 168 women with a new diagnosis of high-grade serous cancer with booked appointments for genetic consultation via the opt-out referral pathway during the study period of January 2015 to December 2017.